Skip to main content
. 2017 Dec 14;9(3):3936–3945. doi: 10.18632/oncotarget.23278

Table 2. Association of rs2294008 with gastritis-gastric cancer sequence.

Cases Controls Cases Controls T vs C TT + TC vs CC
CC CT TT CC CT TT P-valuea ORb (95% CI) P-valuec ORd (95% CI)
Gastric cancere Hp- controls 201 1,087 1,041 73 275 189 4.5 × 10–6 1.37 (1.20–1.57) 4.2 × 10–4 1.67 (1.25–2.22)
Hp+ Hp- controls 41 120 119 73 275 189 0.15 1.14 (0.92–1.41) 0.68 0.92 (0.61–1.39)
Severe gastritis, Hp+ Mild gastritis, Hp+ 13 74 81 27 45 38 1.0 × 10–3 1.93 (1.36–2.76) 9.4 × 10–5 3.88 (1.90–7.92)
Severe gastritis, Hp+ Hp- controls 13 74 81 73 275 189 1.1 × 10–3 1.52 (1.17–1.98) 0.043 1.88 (1.01–3.48)
Gastric cancere Severe gastritis, Hp+ 201 1,087 1,041 13 74 81 0.37 0.90 (0.71–1.15) 0.69 0.89 (0.50–1.59)

Hp+: H. pylori positive, Hp-: H. pylori negative. aP values are calculated by two-sided Cochran-Armitage test. bORs are calculated by considering the C allele as a reference. cP values are calculated by chi-square test. dORs were calculated by considering the CC genotype as a reference. eData from the previous study (Tanikawa et al. 2012 Nature Genetics) 11.